OBJECTIVES: To determine risk factors for GBS colonisation in Gambian mothers and in their infants from birth to day 60-89 of age. METHODS: Swabs and breastmilk from mothers/infant pairs were collected and cultured on selective agar. Negative samples were analysed for GBS DNA via real-time PCR. Positive isolates were serotyped using multiplex PCR and gel-agarose electrophoresis. RESULTS: Seven hundred and fifty women/infant pairs were recruited. 253 women (33.7%) were GBS-colonised at delivery. The predominant serotypes were: V (55%), II (16%), III (10%), Ia (8%) and Ib (8%). 186 infants were colonised (24.8%) at birth, 181 (24.1%) at 6 days and 96 at day 60-89 (14%). Infants born before 34 weeks of gestation and to women with rectovaginal ...
Streptococcus agalactiae (Group B Streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Group B Streptococcus (GBS) is a part of the human microbiome and the leading invasive pathogen in n...
Background: Group B streptococcus (GBS) is a leading neonatal sepsis pathogen globally. Investment i...
SummaryObjectivesTo determine risk factors for GBS colonisation in Gambian mothers and in their infa...
Background: Group B streptococcus (GBS) may be vertically transmitted from mother to infant during l...
OBJECTIVES: Although Staphylococcus aureus and Group B streptococcus (GBS) are major causes of neona...
Background: Vertical GBS transmission is the prerequisite for early-onset disease. Disease protectio...
BACKGROUND: Vertical transmission of Group B Streptococcus (GBS) is a prerequisite for early-onset d...
Background: Maternal colonization of Group B streptococci (GBS) during pregnancy is an important ris...
Background: Maternal colonization of Group B streptococci (GBS) during pregnancy is an important ris...
Group B Streptococcus (GBS, Streptococcus agalactiae) is a leading cause of neonatal infections and ...
Group B streptococcus (GBS), which asymptomatically colonises the vaginal and rectal areas of women,...
Background: Group B streptococcus (GBS), which asymptomatically colonises the vaginal and rectal are...
International audienceMaternal group B Streptococcus (GBS) colonization is a major risk factor for n...
Streptococcus agalactiae (group B streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Streptococcus agalactiae (Group B Streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Group B Streptococcus (GBS) is a part of the human microbiome and the leading invasive pathogen in n...
Background: Group B streptococcus (GBS) is a leading neonatal sepsis pathogen globally. Investment i...
SummaryObjectivesTo determine risk factors for GBS colonisation in Gambian mothers and in their infa...
Background: Group B streptococcus (GBS) may be vertically transmitted from mother to infant during l...
OBJECTIVES: Although Staphylococcus aureus and Group B streptococcus (GBS) are major causes of neona...
Background: Vertical GBS transmission is the prerequisite for early-onset disease. Disease protectio...
BACKGROUND: Vertical transmission of Group B Streptococcus (GBS) is a prerequisite for early-onset d...
Background: Maternal colonization of Group B streptococci (GBS) during pregnancy is an important ris...
Background: Maternal colonization of Group B streptococci (GBS) during pregnancy is an important ris...
Group B Streptococcus (GBS, Streptococcus agalactiae) is a leading cause of neonatal infections and ...
Group B streptococcus (GBS), which asymptomatically colonises the vaginal and rectal areas of women,...
Background: Group B streptococcus (GBS), which asymptomatically colonises the vaginal and rectal are...
International audienceMaternal group B Streptococcus (GBS) colonization is a major risk factor for n...
Streptococcus agalactiae (group B streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Streptococcus agalactiae (Group B Streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Group B Streptococcus (GBS) is a part of the human microbiome and the leading invasive pathogen in n...
Background: Group B streptococcus (GBS) is a leading neonatal sepsis pathogen globally. Investment i...